14:15 – Prevalence and Correlates of Hepatitis C Virus Infection Among People Who Inject Drugs in Tanzania: Findings from Bio-Behavioural Surveys
#19 Mucho Mizinduko, Tanzania
14:18 – Implementation of 3HP Tuberculosis Preventive Therapy Among Clients on ART at Francistown Tebelopele Centre, Botswana
#20 Felistus Othusitse, Botswana
14:21 – Efficacy of Dolutegravir Versus Lopinavir-Based Antiretroviral Treatment Regimens for Infants
#21 Issa Sabi, Tanzania
14:24 – Factors Associated with Non-Use of HIV PrEP Among People Who Inject Drugs Aware of This Prevention Method in Mozambique, 2023–2024
#22 Nazário Carlitos, Mozambique
14:27 – Long-Term Viral Suppression, and Cardiometabolic Benefits of Switch to Ainuovirine Coformulated with Lamivudine, and Tenofovir DF in Virologically Suppressed People with HIV-1: 144-Week, Open-Label Results from the SPRINT Post-Study
#23 Yu Wang, China
14:30 – High Prevalence of Postpartum Depression and Association with Viral Non-Suppression Among Women Living with HIV in Mozambique and Tanzania
#24 Issa Sabi, Tanzania
14:33 – Audience Q&A